Atrimustine
Atrimustine
Atrimustine (pronunciation: a-tri-mus-tine) is a chemotherapy drug used in the treatment of certain types of cancer. It belongs to the class of drugs known as alkylating agents, which work by damaging the DNA of cancer cells and preventing them from dividing and growing.
Etymology
The term "Atrimustine" is derived from the Latin words "atrium" meaning "hall" and "mustine" which is a derivative of the word "mustard". This is in reference to the drug's chemical structure, which is similar to that of mustard gas, a potent alkylating agent.
Usage
Atrimustine is primarily used in the treatment of breast cancer and prostate cancer. It is administered intravenously, usually in combination with other chemotherapy drugs. The exact dosage and treatment schedule depends on the type and stage of the cancer, the patient's overall health, and their response to previous treatments.
Side Effects
Like all chemotherapy drugs, Atrimustine can cause side effects. These may include nausea, vomiting, hair loss, and fatigue. More serious side effects can include anemia, neutropenia (low white blood cell count), and thrombocytopenia (low platelet count). Patients should report any side effects to their doctor immediately.
Related Terms
- Chemotherapy
- Alkylating agent
- Breast cancer
- Prostate cancer
- Nausea
- Vomiting
- Hair loss
- Fatigue
- Anemia
- Neutropenia
- Thrombocytopenia
External links
- Medical encyclopedia article on Atrimustine
- Wikipedia's article - Atrimustine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski